Skip to main content

Table 1 Clinical features of breast carcinoma patients

From: Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma

Variables

Pourcentage (%)

Clinical tumor size

 

T1–T2

62.28

T3–T4

37.72

Lymph node status

 

N(-)

54.2

N(+)

69.12

SBR grading

 

1 – 2

80.88

3

86.76